Does ENCORAFENIB Cause Vitreous floaters? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Vitreous floaters have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.3% of all adverse event reports for ENCORAFENIB.
23
Reports of Vitreous floaters with ENCORAFENIB
0.3%
of all ENCORAFENIB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Vitreous floaters From ENCORAFENIB?
Of the 23 reports, 1 (4.3%) resulted in death, 6 (26.1%) required hospitalization.
Is Vitreous floaters Listed in the Official Label?
Yes, Vitreous floaters is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
BROLUCIZUMAB-DBLL (479)
RANIBIZUMAB (458)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
Which ENCORAFENIB Alternatives Have Lower Vitreous floaters Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN